Loading clinical trials...
Loading clinical trials...
A Double-Blind, Randomized, Placebo-Controlled Clinical Study of the Efficacy of Intravenous Clarithromycin as Adjunctive Treatment in Patients With Sepsis and Respiratory and Multiple Organ Dysfunction Syndrome
Conditions
Interventions
Clarithromycin
Water for injection
Locations
12
Belgium
Intensive Care Unit, Saint-Pierre University Hospital
Brussels, Belgium
Intensive Care Unit, Brugmann University Hospital
Brussels, Belgium
Intensive Care Unit, Erasme University Hospital
Brussels, Belgium
Intensive Care Unit, Korgialeneio-Benakeio General Hospital
Athens, Greece
Intensive Care Unit, Laikon General Hospital
Athens, Greece
2nd Department of Intensive Care Medicine, Attikon University Hospital
Athens, Greece
Start Date
December 15, 2017
Primary Completion Date
September 22, 2019
Completion Date
December 19, 2020
Last Updated
December 22, 2020
NCT04955210
NCT04850456
NCT05267821
NCT07179276
NCT07409727
NCT07448805
Lead Sponsor
Hellenic Institute for the Study of Sepsis
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions